| Cat. No. |
Product Name |
Information |
| PC-72219 |
IMP-1710
UCHL1 inhibitor
|
IMP-1710 (IMP1710) is a potent, selective, covalent UCHL1 inhibitor with IC50 of 38 nM. |
| PC-38192 |
USP7-866
USP7 inhibitor
|
USP7-866 is a novel potent selective inhibitor of USP7 with IC50 of 0.18 nM. |
| PC-38191 |
USP7-797
USP7 inhibitor
|
USP7-797 is a novel potent selective inhibitor of USP7 with IC50 of 0.44 nM. |
| PC-38173 |
FT206
USP28 inhibitor
|
FT206 (FT-206, FT3951206, CRT0511973) is a potent, selectivel inhibitor of USP28 with a remarkable USP28/25 selectivity. |
| PC-38156 |
XL-9872-106C
JOSD1/USP30/UCHL1 inhibitor
|
XL-9872-106C (XL-106C) is a potent, selective inhibitor of the deubiquitinase (DUB) JOSD1/USP30/UCHL1 with IC50 of 134/390/166 nM, respectively. |
| PC-38155 |
SB1-F-70
JOSD1/USP30/UCHL1 inhibitor
|
SB1-F-70 is a potent, selective inhibitor of the deubiquitinase (DUB) JOSD1/USP30/UCHL1 with IC50 of 324/400/400 nM, respectively. |
| PC-38072 |
XL177A
USP7 inhibitor
|
XL177A (XL-177A) is a potent, selective, irreversible USP7 inhibitor with IC50 of 0.34 nM. |
| PC-36022 |
KL001
Cryptochrome modulator
|
KL001 (KL-001) is a small molecule that specifically interacts with cryptochrome (CRY) and small molecule modulator of the circadian clock. |
| PC-35780 |
STD1T
USP2a inhibitor
|
STD1T (USP2a inhibitor STD1T) is a hit-to-lead, small-molecule inhibitor of USP2a with IC50 of 3.3 uM in Ub-AMC assays, displays no activity against USP7 at 10 uM.. |
| PC-35682 |
IU1-248
USP14 inhibitor
|
IU1-248 (USP14 inhibitor IU1-248) is a potent, selective USP14 inhibitor with IC50 of 0.83 uM, IU1-248 is an IU1 derivative that is 10-fold more potent than IU1. |
| PC-35263 |
MF-094
USP30 inhibitor
|
MF-094 (MF094) is a potent, highly selective inhibitor of ubiquitin specific protease 30 (USP30) with IC50 of 0.12 uM, demonstrates <30% inhibitory activity for a panel of 22 USPs assays at 10 uM. |
| PC-63454 |
NSC112200
ZRANB1 inhibitor
|
NSC112200 is a chemical inhibitor of the EZH2 deubiquitinase ZRANB1 (at 10 uM), destabilizes EZH2, promotes proteasomal degradation of EZH2 and inhibits the viability of TNBC cells. |
